iShares Nasdaq US Biotechnology
(BTEK)
£5.15
Previous business day’s close price
+£0.17 (+3.36%)
max available period
£3.91
£5.65
04 Jan 21
01 Jul 24
Details
This ETF tracks Nasdaq listed companies primarily engaged in biomedical research to develop new treatments and cures for human disease, via the Nasdaq Biotechnology index. This ETF reinvests income.
Ticker: BTEK
ISIN: IE00BYXG2H39
Ticker: BTEK
ISIN: IE00BYXG2H39
Key information
ETF Breakdown
AMGEN Inc.
9.0%
Vertex Pharmaceuticals, Inc.
8.7%
Regeneron Pharmaceuticals, Inc.
8.3%
Gilead Sciences, Inc.
7.3%
Moderna Inc
6.1%
Astrazeneca plc
4.7%
Biogen Inc
3.4%
Alnylam Pharmaceuticals Inc
2.0%
Illumina Inc
1.7%
Biomarin Pharmaceutical Inc.
1.5%
Neurocrine Biosciences, Inc.
1.4%
Sanofi
1.4%
Incyte Corp.
1.4%
United Therapeutics Corp
1.3%
Viatris Inc
1.3%
Medpace Holdings Inc
1.2%
Royalty Pharma plc
1.2%
Sarepta Therapeutics Inc
1.2%
argenx SE
1.2%
BioNTech SE
1.0%
Insmed Inc
0.9%
Myovant Sciences Ltd
0.9%
Ascendis Pharma A/S
0.8%
Summit Therapeutics Inc
0.8%
Vaxcyte Inc
0.8%
Jazz Pharmaceuticals plc
0.7%
Blueprint Medicines Corp
0.7%
BeiGene Ltd
0.7%
Intra‑Cellular Therapies Inc
0.7%
Exelixis Inc
0.7%
Revolution Medicines Inc
0.7%
Halozyme Therapeutics Inc.
0.6%
Ionis Pharmaceuticals Inc
0.6%
BridgeBio Pharma Inc
0.5%
Cytokinetics Inc
0.5%
Apellis Pharmaceuticals Inc
0.5%
Krystal Biotech Inc
0.5%
Canticle Pharmaceuticals Inc
0.5%
CRISPR Therapeutics AG
0.5%
ImmunityBio Inc
0.5%
Nuvalent Inc
0.4%
Alkermes plc
0.4%
Immunovant Inc
0.4%
Axsome Therapeutics Inc
0.4%
Legend Biotech Corp
0.4%
Guardant Health Inc
0.3%
Merus N.V
0.3%
Crinetics Pharmaceuticals Inc
0.3%
SpringWorks Therapeutics Inc
0.3%
Ultragenyx Pharmaceutical Inc.
0.3%
Amicus Therapeutics Inc
0.3%
Xenon Pharmaceuticals Inc
0.3%
Arrowhead Pharmaceuticals Inc.
0.3%
Arcellx Inc
0.3%
PTC Therapeutics Inc
0.3%
Ideaya Biosciences Inc
0.3%
Denali Therapeutics Inc
0.3%
Acadia Pharmaceuticals Inc
0.3%
Dyne Therapeutics Inc
0.3%
Lion Biotechnologies Inc
0.3%
NovoCure Ltd
0.3%
Twist Bioscience Corp
0.3%
Vericel Corp
0.2%
Adma Biologics Inc
0.2%
Arvinas Operations Inc
0.2%
Fortrea Holdings Inc
0.2%
Rhythm Pharmaceuticals Inc.
0.2%
Agios Pharmaceuticals Inc
0.2%
Avidity Biosciences Inc
0.2%
Deciphera Pharmaceuticals Inc
0.2%
Intellia Therapeutics Inc
0.2%
Novavax, Inc.
0.2%
Amphastar Pharmaceuticals Inc
0.2%
Beam Therapeutics Inc
0.2%
Myriad Genetics, Inc.
0.2%
Recursion Pharmaceuticals Inc
0.2%
Geron Corp.
0.2%
Kymera Therapeutics Inc
0.2%
Rocket Pharmaceuticals Inc
0.2%
Vera Therapeutics Inc
0.2%
Apogee Therapeutics Ord Shs
0.2%
Harmony Biosciences Holdings Inc
0.2%
Sana Biotechnology Inc
0.2%
Ardelyx Inc
0.2%
Edgewise Therapeutics Inc
0.2%
Fusion Pharmaceuticals Inc
0.2%
Immunocore Holdings plc
0.2%
Keros Therapeutics Inc
0.2%
Protagonist Therapeutics Inc
0.2%
Structure Therapeutics Adr Inc
0.2%
Syndax Pharmaceuticals Inc
0.2%
Dynavax Technologies Corp.
0.2%
Kura Oncology Inc
0.2%
Ligand Pharmaceuticals, Inc.
0.2%
Morphic Holding Inc
0.2%
Veracyte Inc
0.2%
Avadel Pharmaceuticals Ord
0.1%
Pacira BioSciences Inc
0.1%
Supernus Pharmaceuticals Inc
0.1%
Vir Biotechnology Inc
0.1%
Xencor Inc
0.1%
Biocryst Pharmaceuticals Inc.
0.1%
4D Molecular Therapeutics Inc
0.1%
Day One Biopharmaceuticals Inc
0.1%
Genmab
0.1%
Mannkind Corp
0.1%
AbCellera Biologics Inc
0.1%
Maravai LifeSciences Holdings Inc
0.1%
Mirum Pharmaceuticals Inc
0.1%
Prothena Corporation plc
0.1%
Tarsus Pharmaceuticals Inc
0.1%
Akero Therapeutics Inc
0.1%
Collegium Pharmaceutical Inc
0.1%
Cullinan Oncology Inc
0.1%
Arcturus Therapeutics Holdings Inc
0.1%
Enliven Therapeutics Inc Ord
0.1%
Humacyte Inc
0.1%
Innoviva Inc
0.1%
Ironwood Pharmaceuticals Inc
0.1%
Arcutis Biotherapeutics Inc
< 0.1%
CureVac N.V.
< 0.1%
Disc Medicine Inc Ord
< 0.1%
Grifols SA
< 0.1%
Relay Therapeutics Inc
< 0.1%
Silverback Therapeutics Inc
< 0.1%
Zai Lab Limited
< 0.1%
Zentalis Pharmaceuticals Inc
< 0.1%
ANI Pharmaceuticals Inc
< 0.1%
Bicycle Therapeutics Plc
< 0.1%
Cogent Biosciences Inc
< 0.1%
Evolus Inc
< 0.1%
Kiniksa Pharmaceuticals Ltd
< 0.1%
Nurix Therapeutics Inc
< 0.1%
Pliant Therapeutics Inc
< 0.1%
Prime Medicine Ord Shs
< 0.1%
Verona Pharma Plc
< 0.1%
Wave Life Sciences Ltd.
< 0.1%
89bio Inc
< 0.1%
AnaptysBio Inc
< 0.1%
Castle Biosciences Inc
< 0.1%
ITeos Therapeutics Inc
< 0.1%
Lyell Immunopharma Inc
< 0.1%
Ocular Therapeutix Inc
< 0.1%
Regenxbio Inc
< 0.1%
Sage Therapeutics Inc
< 0.1%
Scholar Rock Holding Corp
< 0.1%
Tango Therapeutics Inc
< 0.1%
Adaptive Biotechnologies Corp
< 0.1%
Arbutus Biopharma Corp
< 0.1%
Autolus Therapeutics Adr Plc
< 0.1%
EyePoint Pharmaceuticals Inc
< 0.1%
HUTCHMED (China) Limited
< 0.1%
Harrow Health Inc
< 0.1%
ORIC Pharmaceuticals Inc
< 0.1%
Omniab Inc
< 0.1%
Pacific Biosciences of California Inc
< 0.1%
PetIQ Inc
< 0.1%
Phathom Pharmaceuticals Inc
< 0.1%
SIGA Technologies Inc
< 0.1%
Savara Inc
< 0.1%
Taysha Gene Therapies Inc
< 0.1%
Third Harmonic Bio Ord Shs
< 0.1%
Zymeworks Inc
< 0.1%
Alector Inc
< 0.1%
Alx Oncology Holdings Inc
< 0.1%
Centessa Pharmaceuticals plc
< 0.1%
Fulcrum Therapeutics Inc
< 0.1%
Galapagos NV
< 0.1%
KalVista Pharmaceuticals Inc
< 0.1%
MaxCyte Inc
< 0.1%
Mineralys Therapeutics Ord
< 0.1%
Olema Pharmaceuticals Inc
< 0.1%
Terns Pharmaceuticals Inc
< 0.1%
Travere Therapeutics Inc
< 0.1%
UroGen Pharma Ltd
< 0.1%
Y‑Mabs Therapeutics Inc
< 0.1%
Ac Immune Sa
< 0.1%
Acelyrin Inc.
< 0.1%
Allogene Therapeutics Inc
< 0.1%
Anavex Life Sciences Corporation
< 0.1%
Biomea Fusion Inc
< 0.1%
Cabaletta Bio Inc
< 0.1%
Editas Medicine Inc
< 0.1%
Erasca Inc
< 0.1%
Lexicon Pharmaceuticals Inc
< 0.1%
Nautilus Biotechnology Inc
< 0.1%
Phibro Animal Health Corp.
< 0.1%
Theravance Biopharma Inc
< 0.1%
Tourmaline Bio Inc
< 0.1%
Verve Therapeutics Inc
< 0.1%
Voyager Therapeutics Inc
< 0.1%
ATAI Life Sciences N.V.
< 0.1%
Amarin Corp
< 0.1%
Atea Pharmaceuticals Inc
< 0.1%
Caribou Biosciences Inc
< 0.1%
Exscientia Plc
< 0.1%
Macrogenics Inc
< 0.1%
MeiraGTx Holdings plc
< 0.1%
Precigen Inc
< 0.1%
Replimune Group Inc
< 0.1%
Revance Therapeutics Inc
< 0.1%
Vanda Pharmaceuticals Inc
< 0.1%
Ventyx Biosciences Inc
< 0.1%
Xeris Biopharma Holdings Inc
< 0.1%
23Andme Holding Class A
< 0.1%
Bluebird bio Inc
< 0.1%
Coherus Biosciences Inc
< 0.1%
Ovid Therapeutics Inc
< 0.1%
uniQure N.V.
< 0.1%
Aclaris Therapeutics Inc
< 0.1%
Amylyx Pharmaceuticals Inc
< 0.1%
Marinus Pharmaceuticals Inc
< 0.1%
RAPT Therapeutics Inc
< 0.1%
Reneo Pharmaceuticals Inc
< 0.1%
Others
0.3%
No holdings found.
Please try a different search.
Please try a different search.
North America
81.2%
Europe ex‑UK
6.0%
UK
5.1%
Asia ex‑Japan
0.1%
Emerging Markets
< 0.1%
Rest of the World
7.1%
Healthcare
56.6%
Industrial
22.1%
Technology
7.8%
Consumer
< 0.1%
Sector ‐ Other
13.1%
Why InvestEngine
Unbeatable value
From commission‑free investing, to zero‑ISA fees, we’re proud of our low fees.
Here's how we're able to do it
Here's how we're able to do it
Choice of 660+ ETFs
Low cost, diversified, index‑tracking of stock markets, bonds and commodities.
View our ETF range
View our ETF range
Actionable insights
Know exactly which companies, sectors and regions are in your portfolio.
Powerful automation
Grow your wealth the easy way with automated investing features
Easy diversification
Fractional investing lets you put as little as £1 in any ETF.
DIY or Managed
Build and manage your own portfolio or leave it to us.
